Stay updated on Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial

Sign up to get notified when there's something new on the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The site updated to Revision: v3.3.2, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-26T07:22:30.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Removal of the government funding/operating-status notice from the page does not affect the trial details or core information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-19T08:13:11.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Cali, Colombia was added to the study locations and Santiago de Cali, Colombia was removed.
    Difference
    0.3%
    Check dated 2025-10-28T05:10:05.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 with a government-operating status notice and related links; removed the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T16:00:23.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Updates add current dates, new locations/addresses, and an updated revision version; older locations and outdated addresses are removed. Overall, it reflects a refresh of core identifiers and contact details.
    Difference
    3%
    Check dated 2025-09-29T09:58:30.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Localized the country name from Mexico to México in the address and updated the revision to v3.0.2; the 'Back to Top' link was removed.
    Difference
    1%
    Check dated 2025-09-15T00:21:54.000Z thumbnail image

Stay in the know with updates to Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page.